BioSpace News Archive

Biotech Bay

Scribe Therapeutics to Participate in Upcoming Goldman Sachs The New Guard: Privates Leading the Disruption in Healthcare Investor Conference

Scribe Therapeutics Inc. today announced its participation in the Goldman Sachs The New Guard: Privates Leading The Disruption In Healthcare conference.

April 1, 2022
·
1 min read
Business

Blue Cross and Blue Shield of Minnesota Reports 2021 Financial Results

The Blue Cross and Blue Shield of Minnesota (Blue Cross) family of companies today announced audited financial results for 2021.

April 1, 2022
·
5 min read
Drug Development

Pharming Announces Positive Data from Phase II/III Leniolisib Trial Presented at Clinical Immunology Society 2022 Annual Meeting

Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces new data from the pivotal Phase II/III trial of leniolisib for the treatment of activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome.

April 1, 2022
·
8 min read
Biosimilars Market to Drive Growth 17.5% by 2030 | Potential Opportunity Is Opening in the Coming Years

The global biosimilars market size is projected to hitUS$66.2 billion by 2030 from US$13.5 billion in 2021, indicating an annual growth rate of 17.5% from 2021 to 2030.

April 1, 2022
·
4 min read
Exoskeleton Market Size to Reach USD 1.2 Bn by 2027

The global exoskeleton market size is set to reach over USD 1.2 Billion by the 2027 and is estimated to grow at a CAGR of 21.9% during the forecast period 2021 to 2027.

April 1, 2022
·
5 min read
Biopharmaceutical CMO and CRO Market Expected to Gain 7.4% CAGR by 2030

The global biopharmaceutical CMO and CRO market size is set to grow exponentially. It was valued at USD 31.17billion back in 2021 and is predicted to hit around USD 59.13 billion by 2030, according to Precedence Research.

April 1, 2022
·
5 min read
Pulmonary Arterial Hypertension Market to Reach USD 11.9 Bn by 2030

The Pulmonary Arterial Hypertension Market size was accounted at USD 7 billion in 2021 and estimated to reach USD 11.9 billion by 2030 and growing at a CAGR of 5.9% from 2022 to 2030.

April 1, 2022
·
5 min read
BioMidwest

UCB Showcases Strength of Broad Neurology Portfolio at 74th American Academy of Neurology (AAN) Annual Meeting

UCB announced that new data from its expansive and innovative neurology portfolio will be presented at the 74th American Academy of Neurology Annual Meeting, from April 2-7, 2022.

April 1, 2022
·
42 min read
Deals

Soleno Therapeutics Announces Closing of Approximately $15 Million Underwritten Public Offering

Soleno Therapeutics, Inc. today announced the closing of an underwritten public offering of 40,000,000 shares of its common stock at a public offering price of $0.25 per share.

April 1, 2022
·
6 min read
Business

Biofrontera Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on April 8, 2022

Biofrontera Inc. announced today it will report financial results for the three months and full year ended December 31, 2021 before the opening of the U.S. financial markets on Friday, April 8, 2022 and will host a conference call that same day beginning at 11:00 a.m.

April 1, 2022
·
1 min read